464 results
Page 16 of 24
8-K
EX-99.1
4q8y3w9m5xd xuz9ravm
27 Jan 11
Receives U.S. Regulatory Approval for KOMBIGLYZE™ XR, and First-Line Indication for SPRYCEL® in Fourth Quarter
12:00am
8-K
EX-99.1
f8kqcp5
9 Nov 10
Bristol-Myers Squibb Announces Cash Tender Offer For Up to $750 Million
12:00am
8-K
EX-99.1
z79bx4h
26 Oct 10
Robust Clinical Data and the Strategic Acquisition of ZymoGenetics
12:00am
8-K
EX-99.1
zlf rsp6p5jh7zkfdzz
22 Jul 10
Bristol-Myers Squibb Second Quarter Featured Robust Clinical Data
12:00am
8-K
EX-99.1
sjru09zfdllceokj h2
29 Apr 10
Bristol-Myers Squibb Reports Strong Sales, Earnings Performance in First Quarter
12:00am